These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 34059421)

  • 21. Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices.
    Youssef K; Tandon A; Rezai P
    Integr Biol (Camb); 2019 May; 11(5):186-207. PubMed ID: 31251339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in
    Chalorak P; Sanguanphun T; Limboonreung T; Meemon K
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Butoxytetrahydrofuran, Isolated from
    Promtang S; Sanguanphun T; Chalorak P; Pe LS; Niamnont N; Sobhon P; Meemon K
    ACS Chem Neurosci; 2024 Jun; 15(11):2182-2197. PubMed ID: 38726817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MANF protects dopamine neurons and locomotion defects from a human α-synuclein induced Parkinson's disease model in C. elegans by regulating ER stress and autophagy pathways.
    Zhang Z; Shen Y; Luo H; Zhang F; Peng D; Jing L; Wu Y; Xia X; Song Y; Li W; Jin L
    Exp Neurol; 2018 Oct; 308():59-71. PubMed ID: 29959908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurodifferentiation and Neuroprotection Potential of Mesenchymal Stromal Cell-Derived Secretome Produced in Different Dynamic Systems.
    Marques CR; Fuzeta MA; Dos Santos Cunha RM; Pereira-Sousa J; Silva D; Campos J; Teixeira-Castro A; Sousa RA; Fernandes-Platzgummer A; da Silva CL; Salgado AJ
    Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabidiol Recovers Dopaminergic Neuronal Damage Induced by Reserpine or α-synuclein in Caenorhabditis elegans.
    da Cruz Guedes E; Erustes AG; Leão AHFF; Carneiro CA; Abílio VC; Zuardi AW; Hallak JEC; Crippa JA; Bincoletto C; Smaili SS; Reckziegel P; Pereira GJS
    Neurochem Res; 2023 Aug; 48(8):2390-2405. PubMed ID: 36964823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
    Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
    Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Overview on the Role of α -Synuclein in Experimental Models of Parkinson's Disease from Pathogenesis to Therapeutics.
    Javed H; Kamal MA; Ojha S
    CNS Neurol Disord Drug Targets; 2016; 15(10):1240-1252. PubMed ID: 27658511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
    Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
    Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring Caenorhabditis elegans as Parkinson's Disease Model: Neurotoxins and Genetic Implications.
    da Silva LPD; da Cruz Guedes E; Fernandes ICO; Pedroza LAL; da Silva Pereira GJ; Gubert P
    Neurotox Res; 2024 Feb; 42(1):11. PubMed ID: 38319410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effect of damaurone D in a C. elegans model of Parkinson's disease.
    Lee SH; Han YT; Cha DS
    Neurosci Lett; 2021 Mar; 747():135623. PubMed ID: 33482307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Parkinson activity of bioactive substances extracted from Holothuria leucospilota.
    Malaiwong N; Chalorak P; Jattujan P; Manohong P; Niamnont N; Suphamungmee W; Sobhon P; Meemon K
    Biomed Pharmacother; 2019 Jan; 109():1967-1977. PubMed ID: 30551452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic rescue of α-synuclein-induced neurodegeneration through propionate supplementation and intestine-neuron signaling in C. elegans.
    Wang C; Yang M; Liu D; Zheng C
    Cell Rep; 2024 Mar; 43(3):113865. PubMed ID: 38412096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spermine protects alpha-synuclein expressing dopaminergic neurons from manganese-induced degeneration.
    Vijayan B; Raj V; Nandakumar S; Kishore A; Thekkuveettil A
    Cell Biol Toxicol; 2019 Apr; 35(2):147-159. PubMed ID: 30673990
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Huynh VA; Takala TM; Murros KE; Diwedi B; Saris PEJ
    Front Cell Infect Microbiol; 2023; 13():1181315. PubMed ID: 37197200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylcorynoline attenuates dopaminergic neuron degeneration and α-synuclein aggregation in animal models of Parkinson's disease.
    Fu RH; Wang YC; Chen CS; Tsai RT; Liu SP; Chang WL; Lin HL; Lu CH; Wei JR; Wang ZW; Shyu WC; Lin SZ
    Neuropharmacology; 2014 Jul; 82():108-20. PubMed ID: 23973292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-synuclein inhibits Snx3-retromer-mediated retrograde recycling of iron transporters in S. cerevisiae and C. elegans models of Parkinson's disease.
    Patel D; Xu C; Nagarajan S; Liu Z; Hemphill WO; Shi R; Uversky VN; Caldwell GA; Caldwell KA; Witt SN
    Hum Mol Genet; 2018 May; 27(9):1514-1532. PubMed ID: 29452354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Priming mesenchymal stem cells with α-synuclein enhances neuroprotective properties through induction of autophagy in Parkinsonian models.
    Shin JY; Kim DY; Lee J; Shin YJ; Kim YS; Lee PH
    Stem Cell Res Ther; 2022 Sep; 13(1):483. PubMed ID: 36153562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.